Guardant Health, Inc. GH
Analyst Consensus
Price Objectif
Analyst historical
| Analyste | Entreprise | Prix lors de l'analyse | Prix cible | Gain potentiel | Date de publication |
|---|---|---|---|---|---|
| Kyle Mikson | Canaccord Genuity | 60.18 $ | 75 $ | 14.82 % | 26/09/2025 |
| Mark Massaro | BTIG | 60.75 $ | 80 $ | 19.25 % | 25/09/2025 |
| Daniel Arias | Stifel Nicolaus | 62.64 $ | 73 $ | 10.36 % | 25/09/2025 |
| Doug Schenkel | Wolfe Research | 61.23 $ | 75 $ | 13.77 % | 25/09/2025 |
| Tempus AI | China Renaissance Securities (US) Inc. | 49.9 $ | 70 $ | 20.10 % | 25/06/2025 |
| Dan Leonard | UBS | 27.68 $ | 40 $ | 12.32 % | 21/08/2024 |
| Bill Bonello | Craig-Hallum | 31.365 $ | 37 $ | 5.64 % | 08/08/2024 |
| Tycho Peterson | Jefferies | 33.96 $ | 40 $ | 6.04 % | 08/08/2024 |
| Mark Massaro | BTIG | 35.28 $ | 50 $ | 14.72 % | 29/07/2024 |
| Subbu Nambi | Guggenheim | 28.88 $ | 36 $ | 7.12 % | 28/06/2024 |
| Kyle Mikson | Canaccord Genuity | 27.41 $ | 38 $ | 10.59 % | 04/06/2024 |
| Tycho Peterson | Jefferies | 27.1 $ | 32 $ | 4.90 % | 03/06/2024 |
| Mark Massaro | BTIG | 22.51 $ | 45 $ | 22.49 % | 23/05/2024 |
| Kyle Mikson | Canaccord Genuity | 23.01 $ | 30 $ | 6.99 % | 22/05/2024 |
| Chase Knickerbocker | Craig-Hallum | 17.935 $ | 28 $ | 10.07 % | 24/04/2024 |
| David Westenberg | Piper Sandler | 27.59 $ | 40 $ | 12.41 % | 27/09/2023 |
| Tejas Savant | Morgan Stanley | 41.26 $ | 80 $ | 38.74 % | 16/12/2022 |
| Kyle Mikson | Canaccord Genuity | 41.26 $ | 65 $ | 23.74 % | 16/12/2022 |
| Mason Carrico | Stephens | 59.78 $ | 99 $ | 39.22 % | 05/10/2022 |
| Julia Qin | J.P. Morgan | 39.32 $ | 125 $ | 85.68 % | 09/05/2022 |
| Matthew Sykes | Goldman Sachs | 117.9 $ | 160 $ | 42.10 % | 03/06/2021 |